Efficacy of Bosutinib therapy as a second line in the treatment of chronic myeloid leukemia: A single-center study
BACKGROUND: Chronic myeloid leukemia (CML), a myeloproliferative neoplasm caused by genetic abnormality resulted in BCR-ABL1 fusion gene, leading to constitutive tyrosine kinase activity. Despite improved treatment outcomes of tyrosine kinase inhibitors (TKIs), resistance to these agents due to muta...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Iraqi Journal of Hematology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ijh.ijh_1_25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|